REFRACTORY LEUKEMIA

Clinical trials for REFRACTORY LEUKEMIA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY LEUKEMIA trials appear

Sign up with your email to follow new studies for REFRACTORY LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

New hope for tough leukemia: Triple-Drug attack trial launches

Disease control Not yet recruiting

This early-phase study tests whether adding a new drug called eganelisib to two standard AML treatments (venetoclax and azacitidine) is safe and helps control the disease. It enrolls 48 adults with AML that has returned or not responded to prior therapy. The main goal is to find …

Matched conditions: REFRACTORY LEUKEMIA

Phase: PHASE1 • Sponsor: Jacqueline Garcia, MD • Aim: Disease control

Last updated May 13, 2026 16:00 UTC

REFRACTORY LEUKEMIA

Get alerted when new REFRACTORY LEUKEMIA trials appear

New hope for tough leukemia: Triple-Drug attack trial launches